Tom Lennox

Tom Lennox serves as the Vice President and Head of Market Access at Insulet Corporation since September 2025, leading efforts to enhance formulary access and stakeholder relationships. Previously, Tom held various executive roles at Bristol Myers Squibb from April 2013 to September 2025, including Executive Director positions in payer accounts, portfolio contract strategy, and market access strategic accounts, focusing on negotiating optimal access and reimbursement strategies. Tom's career includes significant roles in other companies such as Health Strategies Group, Piramal Critical Care, Endo, Praecis Pharmaceuticals, Organon, KV Pharmaceutical, and UCB, spanning over two decades in market access and commercialization. Tom holds a BS in Business Administration from Millersville University of Pennsylvania.